Prognostic variables to predict cancer-related death in incidental renal tumours

BJU International
Karim BensalahJean-Jacques Patard

Abstract

To identify, in a large multicentre series of incidental renal tumours, the key factors that could predict cancer-related deaths, as such tumours have a better outcome than symptomatic tumours and selected patients are increasingly being included in watchful-waiting protocols. Data from 3912 patients were extracted from three international kidney-cancer databases. Age, gender, Eastern Cooperative Oncology Group (ECOG) performance status (PS), Tumour-Node-Metastasis (TNM) stage, tumour size, Fuhrman grade, and final pathology were recorded. Benign tumours and malignant lesions with incomplete information were excluded from final analysis. The mean (SD) age of the patients was 60.6 (12.2) years and the mean tumour size 5.5 (3.5) cm. Most tumours were malignant (90.2%) and of low stage (T1-T2, 71.7%) and low grade (G1-G2, 72.4%). There were nodal and distant metastases in 5.7% and 13% of the patients. In all, 525 (14.4%) patients died from cancer; in this group, tumours were >4 cm in 88.2% and had nodal or distant metastases in 20.2% and 49.3%, respectively. Multivariable analysis showed that tumour size >4 cm, ECOG PS >or=1, TNM stage and Fuhrman grade were independent predictors of cancer-related death. A significant proportion ...Continue Reading

References

Jan 1, 1990·European Urology·G VallancienJ M Brisset
Dec 1, 1995·Radiology·M A BosniakJ Waisman
May 11, 1999·JAMA : the Journal of the American Medical Association·W H ChowJ F Fraumeni
Aug 5, 2000·Urology·A J PantuckA Belldegrun
Aug 15, 2002·BJU International·J-J PatardB Lobel
Nov 25, 2003·The Journal of Urology·Igor FrankHorst Zincke
Jul 24, 2004·Magnetic Resonance Imaging Clinics of North America·J Louis Hinshaw, Fred T Lee
Nov 13, 2004·The Journal of Urology·Jean-Jacques PatardAllan J Pantuck
Feb 14, 2006·Nature Clinical Practice. Urology·Alessandro Volpe, Michael A S Jewett
Apr 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pierre I KarakiewiczJean-Jacques Patard
Apr 20, 2007·BJU International·Paul L Crispen, Robert G Uzzo
Jun 15, 2007·The Journal of Urology·Alessandro VolpeMichael A S Jewett

❮ Previous
Next ❯

Citations

Nov 1, 2009·Therapeutic Advances in Medical Oncology·Tanya B DorffDavid I Quinn
Feb 24, 2011·BMC Urology·Nicola N JefferyManish I Patel
Mar 31, 2012·Archives of Pathology & Laboratory Medicine·George J Netto, Liang Cheng
Jul 19, 2011·Hematology/oncology Clinics of North America·Eunyoung ChoPer Lindblad
Apr 13, 2010·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·P BigotJ-J Patard
Nov 3, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·C John SperatiMichael J Choi
Jun 12, 2012·Clinical and Experimental Dermatology·R N MatinC A Harwood
May 5, 2010·Pathology·George J Netto, Jonathan I Epstein

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Otolaryngology and Allied Sciences
MRC Multi-centre Otitis Media Study Group
Proceedings of the National Academy of Sciences of the United States of America
Elke K MarkertArnold J Levine
Techniques in Vascular and Interventional Radiology
R A BaumR M Fairman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Laurence KlotzAndrew Loblaw
© 2022 Meta ULC. All rights reserved